UK Stock Levels: Wegovy vs Mounjaro Dose Availability
Wegovy Mounjaro Equivalent Doses: Current UK Stock Status
Understanding Wegovy and Mounjaro equivalent doses starts with availability – both treatments are fully stocked at EverydayMeds with Reliable UK supply chains. Unlike previous shortage periods, all five Wegovy doses (0.25mg through 2.4mg) ship immediately after prescription approval. Mounjaro's four-dose range similarly maintains consistent stock levels, ensuring treatment continuity. This reliable availability means patients can begin either treatment without delays or waitlists that previously affected UK supply.
The key difference in Wegovy vs Mounjaro equivalent doses lies in their escalation timelines and mechanisms. Wegovy follows a 16-week dose escalation (0.25mg, 0.5mg, 1mg, 1.7mg, then 2.4mg maintenance), while Mounjaro uses four doses over 12-20 weeks (2.5mg, 5mg, 10mg, 15mg maximum). Both prescription-only medicines require careful dose titration to minimise side effects, but neither treatment has true "equivalent" doses due to different active ingredients and receptor targets.
Wegovy Mounjaro Equivalent Doses: Pricing Structure
When comparing Wegovy and Mounjaro equivalent doses, pricing varies significantly across escalation phases. Wegovy starter doses begin at £79.99 (0.25mg) and £94.99 (0.5mg), while maintenance dosing reaches £209.99 (2.4mg). Our bundle options like the Intro Trio (0.25mg, 0.5mg, 1mg) cost £299.99, providing three months of step-up dosing. New customers apply code FIRST40 at checkout, while returning patients use DOSE25 to reach these final prices.
Mounjaro pricing follows a different structure reflecting its dual-agonist formulation, though both treatments require similar long-term investment for sustained weight management. EverydayMeds stocks both options, allowing prescribers to recommend the most suitable treatment based on individual patient factors rather than availability constraints. Bundle pricing ensures treatment continuity without multiple orders, particularly important during dose escalation phases where timing matters for efficacy and tolerability.
Clinical Evidence: Wegovy vs Mounjaro Equivalent Doses
Clinical trials demonstrate distinct efficacy profiles for Wegovy and Mounjaro, though direct dose-to-dose comparisons aren't possible due to different study designs and populations. The STEP 1 trial showed patients taking Wegovy 2.4mg alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks. STEP 5 confirmed sustained weight management with ~15.2% loss maintained at two years.
Mounjaro's SURMOUNT trials evaluated tirzepatide's dual GIP/GLP-1 mechanism across its dose range, with the 15mg maintenance dose showing the highest efficacy in clinical studies. However, comparing trial outcomes between these treatments isn't scientifically valid due to different methodologies, patient populations, and study endpoints. Both Wegovy and Mounjaro are available from EverydayMeds – your prescriber can help determine which treatment aligns with your medical history and weight management goals.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone. This mechanism reduces appetite by acting on brain centres that control food intake, while also slowing gastric emptying to promote satiety after smaller meals. The treatment may help reduce food cravings and the constant thoughts about food that often sabotage weight management efforts. Unlike simple appetite suppressants, Wegovy works through multiple pathways to support long-term weight management when used alongside a reduced-calorie diet and increased physical activity. Each weekly injection maintains steady hormone levels, providing consistent appetite control throughout your treatment journey.
EverydayMeds Ordering Process: Wegovy Mounjaro Equivalent Doses
Accessing either treatment begins with our 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Our UK-registered prescribers review applications within 3 working days (or 24 hours with express service), determining which treatment and starting dose suits your individual circumstances. Once approved, prescriptions are dispensed from our GPhC-registered pharmacy (#9012878) and shipped via next-day delivery using cold-chain temperature-controlled packaging. This process ensures both Wegovy and Mounjaro maintain their potency from pharmacy to patient, with tracking provided for complete peace of mind. Temperature monitors in each package verify optimal storage conditions throughout transit.
Storage and Practical Considerations for Wegovy vs Mounjaro
Storage requirements reveal practical differences when comparing Wegovy and Mounjaro equivalent doses for daily use. Both treatments require refrigeration at 2-8°C before first use, but Wegovy offers superior travel flexibility with 6 weeks room temperature stability (below 30°C) once removed from the fridge. Mounjaro provides 21 days at room temperature, making Wegovy more suitable for extended travel or flexible storage situations. The FlexTouch pen delivery system used by Wegovy provides consistent dosing with clear dose indicators and safety features. Weekly injection timing can be adjusted by up to 3 days if needed, offering lifestyle flexibility while maintaining therapeutic effectiveness. Both treatments use pre-filled pens eliminating dose measurement errors common with traditional injection methods.
UK Supply Chain Reliability: Wegovy Mounjaro Equivalent Doses
EverydayMeds maintains direct supply relationships with Novo Nordisk and Lilly, ensuring consistent availability of all Wegovy and Mounjaro doses throughout the UK. Our inventory management systems track real-time stock levels, preventing the supply disruptions that previously affected weight management treatments. Cold storage facilities across multiple UK locations provide backup supply routes, while automated reordering ensures stock replenishment before shortages occur.
This supply reliability proves particularly crucial during dose escalation phases where treatment interruption can necessitate restarting at lower doses. Patients beginning either treatment can proceed confidently through their dose escalation schedule without availability concerns affecting their progress. Both Wegovy and Mounjaro equivalent doses ship within 24 hours of prescription approval, maintaining treatment momentum essential for long-term success.
Complete Your Assessment Today: Wegovy or Mounjaro Available
Both Wegovy and Mounjaro represent evidence-based approaches to weight management, each with distinct mechanisms and dosing schedules rather than true equivalent doses. Our clinical team helps patients navigate these differences, considering individual medical history, lifestyle factors, and treatment preferences when recommending the most appropriate option. New customers use discount code FIRST40 at checkout, while returning patients apply DOSE25 to access competitive pricing across our full treatment range. Begin your clinical assessment at https://everydaymeds.co.uk/collections/wegovy and receive expert guidance on which treatment offers the best fit for your weight management journey. With both options in stock and ready to ship, there's no need to delay starting your path toward sustainable weight management with professional support every step of the way.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
